Immunic
IMUX
IMUX
55 hedge funds and large institutions have $2.39M invested in Immunic in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
88% less call options, than puts
Call options by funds: $76K | Put options by funds: $659K
97% less capital invested
Capital invested by funds: $95M → $2.39M (-$92.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
55
Holding in Top 10
–
Calls
$76K
Puts
$659K
Top Buyers
| 1 | +$216K | |
| 2 | +$91K | |
| 3 | +$91K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$72.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$63.4K |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$7.5M | |
| 3 | -$6.85M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.59M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.24M |